Asian equities slip as vaccine trials, stimulus talks stall By Reuters

Asian equities slip as vaccine trials, stimulus talks stall By


© Reuters. FILE PHOTO: A TV reporter stands in front of a large screen showing stock prices at the Tokyo Stock Exchange after market opens in Toky

By Suzanne Barlyn and Swati Pandey

NEW YORK/SYDNEY (Reuters) – Asian equities slipped on Wednesday as halted COVID-19 vaccine trials and an impasse in U.S. fiscal aid package talks soured risk appetite, while the greenback held on to gains as demand firmed for safe-harbour assets.

Johnson & Johnson (N:) on Tuesday said it was pausing a COVID-19 vaccine trial due to a study participant’s unexplained illness.

Eli Lilly and Co (N:) later said it too had paused the clinical trial of its COVID-19 antibody treatment due to a safety concern, leading the U.S. equity market to deepen losses.

J&J shares lost 2.3%, while Eli Lilly closed down nearly 3%.

“That just spoke to the fact that a vaccine could take longer to be delivered than what the market’s expectations are calibrated towards,” said CommSec market analyst Tom Piotrowski in Sydney.

MSCI’s broadest index of Asia-Pacific shares outside of Japan () fell 0.2%. Japan’s Nikkei () dipped 0.2% while Australia’s benchmark index () was off a touch and South Korea () stumbled 0.7%.

Chinese shares opened red too with the blue-chip CSI300 () down 0.3%.

Overnight on Wall Street, the Dow Jones Industrial Average () fell 0.5%, the S&P 500 () lost 0.63% and the Nasdaq Composite () eased 0.1%.

Also weighing on sentiment, hopes for the passage of a new coronavirus relief package faded as U.S. House Speaker Nancy Pelosi rejected a $1.8 trillion relief proposal from the White House.

“U.S. stimulus talks are still going nowhere dimming the prospect of a new round of support this side of the election,” said Sydney-based NAB strategist Rodrigo Catril.

“So, for now it is hard to see a deal being agreed before Nov. 3, the market is still travelling with the notion that a new round of stimulus is coming, but at this stage this looks more likely after the election.”

E-mini futures for the S&P 500 were up slightly in early Asian trading.

In currencies, the U.S. dollar boasted its best daily performance in three weeks on Tuesday with its index () against a basket of six major currencies rising 0.5%. The index was last flat at 93.533.

The euro () was barely changed at $1.1742.

The Australian dollar has been slugged by news that China has stopped taking shipments of Australian coal, dragging the to one-week lows. It was last treading water at $0.7163.

The Japanese yen gained versus the greenback to 105.32 per dollar, while sterling was last trading at $1.2932.

Bank of England Governor Andrew Bailey on Tuesday said he did not think the economy was undergoing a V-shaped recovery, because of headwind from a second wave of COVID-19 and underlying public caution about spending and socialising after the pandemic.

Investors are also watching tension between the European Union and Britain after the EU demanded “substantive” movement on Tuesday on fisheries, dispute settlement and guarantees of fair competition in their talks on a post-Brexit trade deal.

EU leaders will hold a summit in Brussels on Thursday and Friday to assess progress.

In commodities, the price was off 0.2% $1,887.33 an ounce.

Oil slipped too, with Brent () and U.S. crude () off 8 cents each at $42.37 and $40.1 a barrel respectively.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *


About us

InvestLab is a financial services technology company focused on the global trading market. Founded in 2010 in Hong Kong, the company develops trading, market data, and social research products that enable individual investors and small to mid-size brokers to access global markets. We provide brokers and financial institutions cross border capabilities for retail investors into 43 markets globally.


CONTACT US

CALL US ANYTIME